Retraction
Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma
Paper Information
Record ID:
55518
Journal:
Publication Date:
March 29, 2022
Retraction Date:
September 27, 2023
(2.1 years years ago)
Subjects:
Institutions:
- Capital Medical University, Beijing 100069, China
- Department of Pharmacy, Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China
- Jianguomen Community Health Service Center, Dongcheng District, Beijing 100005, China
- Xiaotangshan Hospital, Beijing 102211, China
- Department of Hematology, Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Informed/Patient Consent - None/Withdrawn
- Investigation by Journal/Publisher
- Investigation by Third Party
- Lack of IRB/IACUC Approval and/or Compliance
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9806864Citations (3)
3
Total Citations1
Post-Retraction(33.3%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
183
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Generic substitution of amlodipine is not associated with increased risk of mortality or adverse cardiovascular events: An observational cohort study
Boya Zhao, Jing Wu, Chengzhi Lu et al. (4 authors)
Clinical and Translational Science
Open Access
Published: Mar 2024
1 citation
1 citation
183 days after retraction
Retracted: Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma
Journal of Healthcare Engineering
Journal of Healthcare Engineering
Open Access
Published: Jan 2023
269 days before retraction
Quick Stats
Total Citations:
4
Years Since Retraction:
2.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025